Federation des caisses Desjardins du Quebec’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $813K | Buy |
4,815
+511
| +12% | +$87.4K | ﹤0.01% | 1068 |
|
|
2025
Q4 | $726K | Sell |
4,304
-10
| -0.2% | -$1.62K | ﹤0.01% | 1127 |
|
|
2025
Q3 | $623K | Sell |
4,314
-418
| -9% | -$57.1K | ﹤0.01% | 1140 |
|
|
2025
Q2 | $599K | Sell |
4,732
-71
| -1% | -$8.72K | ﹤0.01% | 1000 |
|
|
2025
Q1 | $614K | Buy |
4,803
+4,058
| +545% | +$550K | ﹤0.01% | 965 |
|
|
2024
Q4 | $98.5K | Sell |
745
-106
| -12% | -$14.9K | ﹤0.01% | 1277 |
|
|
2024
Q3 | $124K | Sell |
851
-297
| -26% | -$43K | ﹤0.01% | 1209 |
|
|
2024
Q2 | $158K | Buy |
1,148
+38
| +3% | +$5.07K | ﹤0.01% | 1163 |
|
|
2024
Q1 | $152K | Buy |
1,110
+260
| +31% | +$35.5K | ﹤0.01% | 1131 |
|
|
2023
Q4 | $115K | Sell |
850
-115
| -12% | -$14K | ﹤0.01% | 1083 |
|
|
2023
Q3 | $118K | Buy |
965
+6
| +0.6% | +$763 | ﹤0.01% | 1083 |
|
|
2023
Q2 | $122K | Hold |
959
| – | – | ﹤0.01% | 1108 |
|
|
2023
Q1 | $124K | Sell |
959
-23
| -2% | -$3.01K | ﹤0.01% | 1096 |
|
|
2022
Q4 | $129K | Buy |
982
+78
| +9% | +$10.1K | ﹤0.01% | 1183 |
|
|
2022
Q3 | $106K | Sell |
904
-151
| -14% | -$18.8K | ﹤0.01% | 1299 |
|
|
2022
Q2 | $124K | Sell |
1,055
-150
| -12% | -$17.8K | ﹤0.01% | 1264 |
|
|
2022
Q1 | $157K | Sell |
1,205
-370
| -23% | -$48.2K | ﹤0.01% | 1216 |
|
|
2021
Q4 | $240K | Buy |
1,575
+110
| +8% | +$17K | ﹤0.01% | 1099 |
|
|
2021
Q3 | $237K | Buy |
1,465
+95
| +7% | +$16K | ﹤0.01% | 1119 |
|
|
2021
Q2 | $224K | Buy |
1,370
+162
| +13% | +$25K | ﹤0.01% | 1147 |
|
|
2021
Q1 | $182K | Hold |
1,208
| – | – | ﹤0.01% | 1148 |
|
|
2020
Q4 | $183K | Sell |
1,208
-207
| -15% | -$29.6K | ﹤0.01% | 1087 |
|
|
2020
Q3 | $192K | Buy |
1,415
+529
| +60% | +$71.8K | ﹤0.01% | 885 |
|
|
2020
Q2 | $121K | Hold |
886
| – | – | ﹤0.01% | 981 |
|
|
2020
Q1 | $95.5K | Sell |
886
-60
| -6% | -$6.91K | ﹤0.01% | 1061 |
|
|
2019
Q4 | $114K | Sell |
946
-3,176
| -77% | -$354K | ﹤0.01% | 1267 |
|
|
2019
Q3 | $410K | Hold |
4,122
| – | – | 0.01% | 827 |
|
|
2019
Q2 | $450K | Buy |
4,122
+982
| +31% | +$104K | 0.01% | 808 |
|
|
2019
Q1 | $351K | Hold |
3,140
| – | – | 0.01% | 815 |
|
|
2018
Q4 | $303K | Sell |
3,140
-60
| -2% | -$6.37K | 0.01% | 840 |
|
|
2018
Q3 | $390K | Buy |
3,200
+661
| +26% | +$77.8K | 0.01% | 804 |
|
|
2018
Q2 | $279K | Buy |
2,539
+35
| +1% | +$3.74K | ﹤0.01% | 964 |
|
|
2018
Q1 | $267K | Sell |
2,504
-319
| -11% | -$35.4K | ﹤0.01% | 926 |
|
|
2017
Q4 | $301K | Sell |
2,823
-621
| -18% | -$66.4K | ﹤0.01% | 939 |
|
|
2017
Q3 | $383K | Sell |
3,444
-1,758
| -34% | -$188K | 0.01% | 811 |
|
|
2017
Q2 | $538K | Buy |
+5,202
| New | +$512K | 0.01% | 713 |
|
Other funds holding IBB
CB
Federation des caisses Desjardins du Quebec's IBB Position: Q1 2026 in Review
Federation des caisses Desjardins du Quebec increased its iShares Biotechnology ETF (IBB) stake by 12% in Q1 2026, buying an estimated $87.4K and bringing the position to 4,815 shares worth $813K. The position accounts for ﹤0.01% of the portfolio, ranked #1068.
Federation des caisses Desjardins du Quebec first reported a position in IBB in Q2 2017 and has held it in 36 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Federation des caisses Desjardins du Quebec held 4,815 shares of iShares Biotechnology ETF worth $813K as of Q1 2026.
- Federation des caisses Desjardins du Quebec bought 511 iShares Biotechnology ETF shares in Q1 2026, an estimated $87.4K.
- iShares Biotechnology ETF made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #1068 holding.
- Federation des caisses Desjardins du Quebec first reported a position in iShares Biotechnology ETF in Q2 2017 and has held it in 36 quarters since.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.